Home
Lynx1 Capital Management, 10% Owner: Neuphoria Therapeutics NEUP Buy · Filed 25/10/23
Trade details
- Type
- Insider buy
- Amount
- $3,285,025.4
- Shares · price
- 639,110 sh · $5.14 a share
- Held after
- 875,328 sh
- Trade date
- 25/10/21
- Filed
- 25/10/23
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 2 insiders
- Holding change
- +270.6%
Neuphoria Therapeutics trades, last 26 weeks
What else happened in Neuphoria Therapeutics around then
Filed or reported within 30 days of the trade day · 25/09/21~25/11/20Lynx1 Capital Management's recent trades
- Lynx1 Capital Management
BuyPassage BIO
BuyPassage BIO
PASG
$206.2K
50,055 sh
$206.2K
Filed 06/29
Traded 06/25
- Lynx1 Capital Management
BuyKorro Bio
BuyKorro Bio
KRRO
$5,512
520 sh
$5,512
Filed 04/02
Traded 03/31
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$72.1K
80,069 sh
$72.1K
Filed 25/12/23
Traded 25/12/19
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$68K
75,500 sh
$68K
Filed 25/12/23
Traded 25/12/22
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$5,609
6,232 sh
$5,609
Filed 25/12/23
Traded 25/12/23
